Compositions and methods for delivery of frozen particle adhesives
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-009/00
A61K-009/16
A61K-009/08
A61K-031/00
A61K-051/12
A61K-009/19
A61K-031/10
A61K-031/337
A61K-031/70
A61K-031/7088
A61K-033/00
A61K-041/00
A61K-045/06
A61K-049/18
A61K-039/00
출원번호
US-0383260
(2009-03-20)
등록번호
US-9056047
(2015-06-16)
발명자
/ 주소
Boyden, Edward S.
Cook, Daniel B.
Hyde, Roderick A.
Leuthardt, Eric C.
Myhrvold, Nathan P.
Sweeney, Elizabeth A.
Wood, Jr., Lowell L.
출원인 / 주소
The Invention Science Fund I, LLC
인용정보
피인용 횟수 :
2인용 특허 :
144
초록▼
Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at low temperatures. In certain embodiments, the frozen particles provide vehicles for delivery of particula
Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at low temperatures. In certain embodiments, the frozen particles provide vehicles for delivery of particular agents. In certain embodiments, the frozen particles are administered to at least one biological tissue.
대표청구항▼
1. A frozen particle composition, comprising: one or more frozen solvent particles approximately 10 micrometers or smaller in size and including at least one of acetone, ethyl acetate, dimethyl sulfoxide, dimethyl formamide, dioxane, tetrahydrofuran, acetronitrile, n-butanol, isopropanol, n-propanol
1. A frozen particle composition, comprising: one or more frozen solvent particles approximately 10 micrometers or smaller in size and including at least one of acetone, ethyl acetate, dimethyl sulfoxide, dimethyl formamide, dioxane, tetrahydrofuran, acetronitrile, n-butanol, isopropanol, n-propanol, hexamethylphosphorotriamide, perfluorohydrocarbon, methanol, tert-butyl alcohol, formic acid, hydrogen fluoride, benzene, carbon tetrachloride, acetonitrile, hexane, dichloromethane, methylene chloride, methane, toluene, chloroform, or diethyl ether; and having at least one first compartment with at least one adhesive agent located in the at least one first compartment;wherein the at least one adhesive agent includes one or more of acrylamide polymer or copolymer, fibrin, fibrinogen, thrombin, chitin, collagen, or glycosaminoglycan;at least one second compartment with at least one therapeutic agent located in the at least one second compartment; wherein the at least one therapeutic agent includes one or more of an alkylating agent, antimetabolite, anthracycline, plant alkaloid, topoisomerase inhibitor, monoclonal antibody, or tyrosine kinase inhibitor. 2. The frozen particle composition of claim 1, further including at least one of polyethylene glycol, Ringer's solution, lactated Ringer's solution, Hartmann's solution, acetated Ringer's solution, phosphate buffered solution, TRIS-buffered saline solution, Hank's balanced salt solution, Earle's balanced salt solution, HEPES-buffered saline, dextrose, or glucose. 3. The frozen particle composition of claim 1, wherein the at least one adhesive agent includes at least one of a monomer, prepolymer, polymer, or copolymer. 4. The frozen particle composition of claim 3, wherein the at least one adhesive agent includes at least one monomer of a self-polymerizing agent. 5. The frozen particle composition of claim 3, wherein the at least one adhesive agent includes at least one nontoxic, biocompatible, bioresorbable, or biodegradable agent. 6. The frozen particle composition of claim 3, wherein the at least one adhesive agent is configured to polymerize upon administration to at least one substrate. 7. The frozen particle composition of claim 6, wherein the at least one adhesive agent is configured to polymerize at or above the temperature of the at least one substrate. 8. The frozen particle composition of claim 1, wherein the at least one adhesive agent is configured to polymerize at or above the temperature of at least one biological tissue. 9. The frozen particle composition of claim 1, wherein the at least one adhesive agent is configured to polymerize at or above the temperature of at least one subject. 10. The frozen particle composition of claim 1, further including at least one material that modulates the rate of diffusion or degradation of the at least one adhesive agent. 11. The frozen particle composition of claim 1, wherein the at least one adhesive agent includes at least one crosslinking or derivatized agent. 12. The frozen particle composition of claim 1, further including at least one therapeutic agent including at least one cytokine. 13. The frozen particle composition of claim 1, wherein the at least one adhesive agent includes a methacrylate. 14. The frozen particle composition of claim 13, wherein the at least one adhesive agent includes at least one of poly(N,N-dimethyl-N-(ethoxycarbonylmethyl)-N-[2′-(methacryloyloxy)ethyl]-ammonium bromide) or poly(sulfobetaine methacrylate). 15. The frozen particle composition of claim 1, formulated to be administered to at least one substrate, including one or more of a cell, tissue, organ, structure, or device. 16. The frozen particle composition of claim 1, wherein the at least one adhesive agent includes a detectable state that varies with its adhesive state. 17. The frozen particle composition of claim 1, wherein the at least one adhesive agent further includes one or more of a base component, initiator component, or activator component. 18. The frozen particle composition of claim 1, wherein the at least one adhesive agent further includes at least one curing component. 19. The frozen particle composition of claim 1, wherein the adhesive agent includes at least one dye coinitiator. 20. A method for providing at least one adhesive agent to at least one substrate, comprising: administering at least one frozen particle composition to at least one substrate, wherein the at least one frozen particle composition includes one or more frozen solvent particles approximately 10 micrometers or smaller in size and including at least one of acetone, ethyl acetate, dimethyl sulfoxide, dimethyl formamide, dioxane, tetrahydrofuran, acetronitrile, n butanol, isopropanol, n-propanol, hexamethylphosphorotriamide, perfluorohydrocarbon, methanol, tert-butyl alcohol, formic acid, hydrogen fluoride, benzene, carbon tetrachloride, acetonitrile, hexane, dichloromethane, methylene chloride, methane, toluene, chloroform, or diethyl ether; and having at least one first compartment with at least one adhesive agent located in the at least one first compartment;wherein the at least one adhesive agent includes one or more of acrylamide polymer or copolymer, fibrin, fibrinogen, thrombin, chitin, collagen, or glycosaminoglycan;at least one second compartment with at least one therapeutic agent located in the at least one second compartment;wherein the at least one therapeutic agent includes one or more of an alkylating agent, antimetabolite, anthracycline, plant alkaloid, topoisomerase inhibitor, monoclonal antibody, or tyrosine kinase inhibitor. 21. The method of claim 20, further including at least one of polyethylene glycol, Ringer's solution, lactated Ringer's solution, Hartmann's solution, acetated Ringer's solution, phosphate buffered solution, TRIS-buffered saline solution, Hank's balanced salt solution, Earle's balanced salt solution, HEPES-buffered saline, dextrose, or glucose. 22. The method of claim 20, wherein the at least one substrate includes one or more of a cell, tissue, organ, structure, or device. 23. The method of claim 22, wherein the structure includes one or more of a prosthesis, cell matrix, or tissue matrix. 24. The method of claim 22, wherein the at least one substrate includes at least one cell mass. 25. The method of claim 20, wherein the at least one substrate includes one or more wounds. 26. The method of claim 20, wherein administering at least one frozen particle composition to at least one substrate includes accelerating, propelling, or ejecting the frozen particle composition toward the at least one substrate. 27. The method of claim 20, further including varying the rate, velocity, or angle at which the at least one frozen particle composition is administered to at least one substrate. 28. The method of claim 20, wherein two or more of a plurality of frozen particle compositions include two or more adhesive agents that are configured to physically or chemically bind upon administration. 29. The method of claim 20, further including administering to the at least one substrate at least one of a nanoparticle, detection material, sensor, micro-syringe, or circuit. 30. The method of claim 20, wherein the at least one adhesive agent includes a detectable state that varies with its adhesive state. 31. The method of claim 20, wherein the at least one adhesive agent further includes one or more of a base component, initiator component, or activator component. 32. The method of claim 20, wherein the at least one adhesive agent further includes at least one curing component. 33. The method of claim 20, wherein the adhesive agent includes at least one dye coinitiator. 34. A frozen particle composition, comprising: one or more frozen particles approximately 100 microns or smaller in size and including at least one adhesive agent including one or more of acrylamide polymer or copolymer, selectin, methacrylate, silicone, glutaraldehyde, polyethylene glycol, anti-CD64 binding domain, or polysulfide;at least one therapeutic agent including a chemotherapy drug;at least one abrasive including at least one of alluvium, sand, calcite, emery, diamond, novaculite, pumice, borazon, corundum, or zirconia alumina;and at least one reinforcement agent including silica beads.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (144)
Phillips William T. (San Antonio TX) Klipper Robert W. (San Antonio TX) Timmons James H. (Tacoma WA) Rudolph Alan S. (Bowie MD), 99m TC labeled liposomes.
Smits Georges (Gijzegem-Aalst BEX) Daenekindt Luc (Gijzegem-Aalst BEX) Booten Karl (Geetbets BEX), Agglomerated composition, process for producing it and food products containing the said composition.
Armstrong Jay (1543 Weymouth Cir. ; Apt. 109 Westlake OH 44145) Becker James R. (6272 Mills Creek La. North Ridgeville OH 44039), Blast cleaning system.
Topalian Harry H. (Dover DE) Wyss Clement R. (Lewes DE) Kenyon Ralph E. (Dover DE) Dec Anthony F. (Dover DE), Frozen aerated ready-to-eat gelatin composition.
Brinegar Chris (587 Locksley Rd. Boulder Creek CA 95006) Gilmore James (6385 Camino Verde Dr. San Jose CA 95119) Johnson Michael (6385 Camino Verde Dr. San Jose CA 95119) Walker Nigel (5385 Broadway , Ice-mediated introduction of substances into biological material.
Thomas Dag Horn ; Sandra Marchese Johnson, Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction.
Rahman Aquilur (Gaithersburg MD) Rafaeloff Rafael (Tel-Aviv MD ILX) Husain Syed R. (Gaithersburg MD), Liposome encapsulated taxol and a method of using the same.
Weaver, James C.; Anderson, R. Rox; Herndon, Terry O; Gowrishankar, T. R.; Gift, Elizabeth A.; Gonzalez, Salvador, Localized molecular and ionic transport to and from tissues.
Poulsen, Jens Ulrik; Christensen, Lars Hofmann; Aasmul, S.o slashed.ren, Method and a system for assisting a user in a medical self treatment, said self treatment comprising a plurality of actions.
Power Wendy ; Reed Michael A. ; Frustaci Dominick J. ; Larocque Gerald ; Marchetti Brenda, Method and apparatus for determining quantity of liquid in a container and/or lack of motion thereof.
Westergaard Knud E. (Rolighedsvej 16 9560 Hadsund DKX), Method and apparatus for particle blasting using particles of a material that changes its state.
Frohlich, Hans; Gebhardt, Sabine; Trampusch, Berthold, Method and device for generating a two-phase gas-particle jet, in particular containing CO2 dry ice particles.
Cates Michael C. (Solana Beach CA) Hamm Richard R. (San Diego CA) Lewis Michael W. (Wichita KS) Schmitz Wayne N. (St. Louis MO), Method and system for removing a coating from a substrate using radiant energy and a particle stream.
Costantino Henry R. ; Jaworowicz Warren E. ; Tracy Mark A. ; Beganski Christopher P., Method of producing sub-micron particles of biologically active agents and uses thereof.
Cummins Thomas J. (Rochester NY) Ekeze Tobias D. (Rochester NY), Methods of extracting nucleic acids and PCR amplification without using a proteolytic enzyme.
Rhim Won-Kyu (Pasadena CA) Hyson Michael T. (Glendale CA) Chung Sang-Kun (Diamond Bar CA) Colvin Michael S. (Malibu CA) Chang Manchium (Los Angeles CA), Monodisperse, polymeric microspheres produced by irradiation of slowly thawing frozen drops.
Shih, Hong; Leonte, Oana M.; Daugherty, John E.; Huang, Tuochuan; Goldspring, Gregory J.; May, Michael C., On-line chamber cleaning using dry ice blasting.
Clark ; Jr. William G. (Murrysville PA) Herald John J. (Monroeville PA) Liaw Peter K. (Knoxville TN), Pressurized ferrofluid paint removal system using an electromagnet and eddy current encircling coil to adjust weight per.
Fages Jacques,FRX ; Marty Alain,FRX ; Combes Didier,FRX ; Condoret Jean-Stephane,FRX, Process for treating bone tissue and corresponding implantable biomaterials.
Clauss Steven L. (Manville NJ) Pastel Michael J. (Highland Mills NY) Zawadzki Rainer K. (Wuhan CNX), Stable porfimer sodium compositions and methods for their manufacture.
Boyden, Edward S.; Cook, Daniel B.; Hyde, Roderick A.; Leuthardt, Eric C.; Myhrvold, Nathan P.; Sweeney, Elizabeth A.; Wood, Jr., Lowell L., Systems, devices, and methods for making or administering frozen particles.
Santa Cruz Cathy D. ; Deniston-Korgol Christine L. ; Baugh Barbara I. ; Baugh Alexandria D. ; Baugh Roger D., Weather-proof wrist, forearm, and elbow protectors.
Dean ; Jr. Robert C. (Norwich VT) Silver Frederick H. (Long Valley NJ) Berg Richard A. (Lambertville NJ) Phillips Philip G. (Norwich VT) Runstadler ; Jr. Peter W. (Hanover NH), Weighted collagen microsponge for immobilizing bioactive material.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.